查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519360

2024-2032 年按产品类型、类型、细胞类型、分子类型、最终用户和地区分類的一次性生物反应器市场报告

Single-Use Bioreactors Market Report by Product Type, Type, Cell Type, Molecule Type, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球一次性生物反应器市场规模达34亿美元。对生物製药的需求不断增长、产品提供的成本效益和可扩展性、一次性技术的重大发展、合约製造组织(CMO) 中产品采用率的增加、细胞和基因治疗生产中使用率的增加，推动了市场的发展。

一次性生物反应器市场分析：

主要市场驱动因素：对生物製药的需求不断增长、产品提供的成本效益和可扩展性以及一次性技术的重大发展是主要的市场驱动因素。

主要市场趋势：合约製造组织 (CMO) 的产品采用率不断提高、细胞和基因治疗生产的利用率不断提高以及生物反应器设计的显着进步是一些一次性生物反应器的主要市场趋势。

地理趋势：由于生物製药的使用不断增加、生物加工技术的投资不断增加以及一次​​性系统比传统钢製生物反应器带来的效益不断增加，北美在市场上占据主导地位。

竞争格局：ABEC Inc.、Cellexus、Celltainer Biotech BV、CESCO Bioengineering Co. Ltd.、Distek Inc.、Eppendorf SE、General Electric Company、Getinge AB、Merck KGaA、Pall Corporation (Danaher Corporation)、PBS Biotech Inc.、Sartorius AG 和Thermo Fisher Scientific Inc. 是一次性生物反应器行业的一些主要参与者。

挑战与机会：该行业面临的一些挑战包括高昂的初始产品成本和对塑胶废物日益增加的担忧。然而，市场机会包括单一生物反应器设计的重大技术发展以及对个人化医疗和小批量生产不断增长的需求。

一次性生物反应器市场趋势：

生物製药的采用不断增加

由于对多种疾病（包括糖尿病、癌症和自体免疫疾病等慢性病）的新的有效治疗方法的需求不断增加，生物製药行业正在快速增长。根据IMARC GROUP统计，2023年全球生物製药市场规模已达3,005亿美元，预计到2032年将达到6,439亿美元，2024-2032年复合年增长率为8.6%。拥有疫苗、单株抗体和重组蛋白的生物製药是利用活细胞生产的，需要高度专业的生产环境。一次性生物反应器（SUB）因其成本效益、灵活性和交叉污染风险降低而被广泛采用。它们可以缩短产品开发和生产时间，从而使生物製药公司能够快速满足这些需求并为患者开发新疗法。

生物加工技术投资不断增加

随着生物加工技术寻求提高生产能力和提高营运效率，对生物加工技术的投资不断增加。根据IMARC GROUP发布的报告，2023年全球生物製程技术市场规模已达292亿美元，预计到2032年将达到533亿美元，2024-2032年复合年增长率为6.93%。一次性生物反应器能够透过提供多种优势来组织生物加工工作流程，例如减少资本支出、最大限度地减少清洁和验证要求以及在扩大或缩小产量方面具有更好的灵活性。主要参与者正在大力投资一次性技术，以最大限度地提高生产流程、最大限度地减少停机时间并实现成本效益。

有利的监管支持和有利的政府政策

监管机构和政府机构透过确保产品安全、功效和品质的持久指导方针和框架，在发展生物製药製造格局方面发挥着重要作用。近年来，监管界越来越认识到一次性生物反应器（SUB）的好处。美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等监管机构一直支持一次性技术，因为它们能够降低污染风险并提高流程效率。这种监管支持为 SUB 的采用提供了有利的环境，鼓励生物製药公司投资这些系统。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球一次性生物反应器市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 一次性生物反应器系统
    • 市场走向
    • 市场预测
  • 媒体袋
    • 市场走向
    • 市场预测
  • 过滤组件
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按类型

  • 搅拌槽生物反应器
    • 市场走向
    • 市场预测
  • 波诱导生物反应器
    • 市场走向
    • 市场预测
  • 鼓泡柱生物反应器
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场细分：按电池类型

  • 哺乳动物细胞
    • 市场走向
    • 市场预测
  • 细菌
    • 市场走向
    • 市场预测
  • 酵母菌
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：依分子类型

  • 疫苗
    • 市场走向
    • 市场预测
  • 单株抗体
    • 市场走向
    • 市场预测
  • 干细胞
    • 市场走向
    • 市场预测
  • 重组蛋白
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 製药和生物製药公司
    • 市场走向
    • 市场预测
  • 合约研究组织
    • 市场走向
    • 市场预测
  • 学术及研究机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • ABEC Inc.
    • Cellexus
    • Celltainer Biotech BV
    • CESCO Bioengineering Co. Ltd.
    • Distek Inc.
    • Eppendorf SE
    • General Electric Company
    • Getinge AB
    • Merck KGaA
    • Pall Corporation (Danaher Corporation)
    • PBS Biotech Inc.
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A5151

The global single-use bioreactors market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.1 Billion by 2032, exhibiting a growth rate (CAGR) of 13.8% during 2024-2032. The market is propelled by the increasing demand for biopharmaceuticals, cost-efficiency and scalability offered by the product, significant developments in single-use technology, increasing product adoption in contract manufacturing organizations (CMOs), rising usage in cell and gene therapy production.

Single-Use Bioreactors Market Analysis:

Major Market Drivers: Increasing demand for biopharmaceuticals, cost-efficiency and scalability offered by the product, and significant developments in single-use technology are some of the major market drivers.

Key Market Trends: Growing product adoption in contract manufacturing organizations (CMOs), increasing utilization in cell and gene therapy productions, and significant advancements in bioreactor design are some single-use bioreactors key market trends.

Geographical Trends: North America dominates the market on account of the increasing usage of biopharmaceuticals, rising investment in bioprocessing technologies, and growing benefits of single-use systems more than conventional-steel bioreactors.

Competitive Landscape: ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc., are among some of the key players in the single-use bioreactors industry.

Challenges and Opportunities: Some of the challenges of the industry include high initial product costs and increasing concerns about plastic waste. Whereas, opportunities of the market include the significant technological developments in single-bioreactor designs and the rising demand for personalized medicine and small-batch production.

Single-Use Bioreactors Market Trends:

Rising Adoption of Biopharmaceuticals

The biopharmaceutical industry is rapidly growing on account of the increasing demand for new and effective treatments for numerous diseases, including chronic diseases, such as diabetes, cancer, and autoimmune disorders. According to the IMARC GROUP, the global biopharmaceuticals market has reached US$ 300.5 Billion in 2023, and is expected to reach US$ 643.9 Billion by 2032, exhibiting a CAGR of 8.6% during 2024-2032. Biopharmaceuticals which possess vaccines, monoclonal antibodies, and recombinant proteins, are produced using living cells, which need highly specialized production environments. Single-use bioreactors (SUBs) are highly adopted on account of their cost-efficiency, flexibility, and reduced risk of cross-contamination. They allow quicker product development and production times, thus enabling biopharmaceutical companies to rapidly cater to these demands and develop new therapies for patients.

Rising Investment in Bioprocessing Technologies

The rising investment in bioprocessing technologies is increasing as they seek to improve their production capabilities and enhance operational efficiencies. As per a report published by the IMARC GROUP, the global bioprocess technology market has reached US$ 29.2 Billion in 2023, and is expected to reach US$ 53.3 Billion by 2032, exhibiting a CAGR of 6.93% during 2024-2032. Single-use bioreactors are able to organize the bioprocessing workflow by offering a wide variety of benefits such as reduced capital expenditure, minimized cleaning and validation requirements, and better flexibility in scaling up or down production volumes. Key players are extensively investing in single-use technologies to maximize their production processes, minimize downtime, and achieve cost-efficiency.

Favorable Regulatory Support and Favorable Government Policies

Regulatory agencies and government bodies play a major role in evolving the landscape of biopharmaceutical manufacturing by enduring guidelines and frameworks that guarantee product safety, efficacy, and quality. In recent years, there has been a growing recognition of the benefits of single-use bioreactors (SUBs) within the regulatory community. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have been supportive of single-use technologies due to their ability to reduce contamination risks and improve process efficiencies. This regulatory support has provided a conducive environment for the adoption of SUBs, encouraging biopharmaceutical companies to invest in these systems.

Single-Use Bioreactors Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, type, cell type, molecule type, and end user.

Breakup by Product Type:

Single-use Bioreactor Systems

Media Bags

Filtration Assemblies

Others

Single-use bioreactor systems accounts for the majority of the market share

The single-use bioreactors market report has provided a detailed breakup and analysis of the market based on the product type. This includes single-use bioreactor systems, media bags, filtration assemblies, and others. According to the report, single-use bioreactor systems represented the largest segment.

Single-use bioreactor systems dominate the market on account of the numerous benefits offered by them. These are meant for single time usage, which eliminates the need of the vigorous cleaning and sterilization procedure that stainless-steel bioreactors need. This in turn minimizes the downtime between production runs, improves operational efficiency, and reduces the risk of cross-contamination, which is vital in biopharmaceutical production.

Breakup by Type:

Stirred-tank Bioreactors

Wave-induced Bioreactors

Bubble-column Bioreactors

Others

Stirred tank bioreactors holds the largest share in the industry

A detailed breakup and analysis of the market based on the type have also been provided in the report. This includes stirred-tank bioreactors, wave-induced bioreactors, bubble-column bioreactors, and others. According to the report, stirred tank bioreactors accounted for the largest market share.

Stirred tank bioreactors hold maximum number of single-use bioreactors market share on account of their efficiency, scalability, and versatility in a wide variety of bioprocessing applications. These bioreactors are built to offer optimized mixing and aeration conditions, which are vital for maintaining uniform cell culture environments and achieving high cell densities and product results. This type of single-use bioreactors is appropriate for both microbial and mammalian cell cultures, thereby making it a preferred choice for creating a wide variety of biopharmaceutical products, such as vaccines, monoclonal antibodies, and recombinant proteins.

Breakup by Cell Type:

Mammalian Cell

Bacteria

Yeast

Others

Mammalian cell represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the cell type. This includes mammalian cell, bacteria, yeast, and others. According to the report, mammalian cell represented the largest segment.

Mammalian cells hold the largest market share due to several critical factors. Initially, mammalian cells are critical for producing complex biopharmaceuticals such as monoclonal antibodies, recombinant proteins, and vaccines. These therapeutic agents need mammalian cells for their post-translational modifications, which are crucial for their functional and structural integrity. Unlike microbial or yeast cells, mammalian cells can perform glycosylation and other modifications that are vital for the efficacy and safety of biopharmaceutical products. Mammalian cells possess the ability to produce human-like glycosylation patterns which further makes them irreplaceable for the development of biologics that need to mimic natural human proteins closely.

Breakup by Molecule Type:

Vaccines

Monoclonal Antibodies

Stem Cells

Recombinant Proteins

Others

Vaccines exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the molecule type have also been provided in the report. This includes vaccines, monoclonal antibodies, stem cells, recombinant proteins, and others. According to the report, vaccines accounted for the largest market share.

Vaccines represent the largest segment due to several compelling factors, such as the rising global demand for vaccines, driven by the continuous upsurge of infectious diseases and the need for rapid and effective immunization strategies. The COVID-19 pandemic is a notable instance that has underlined the importance of vaccines, promoting unprecedented investments in vaccine research, development, and production. Single-use bioreactors have become indispensable in this context because of their flexibility, scalability, and ability to support quick production cycles, which are critical for meeting urgent vaccine demands.

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Contract Research Organizations

Academic and Research Institutes

Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes pharmaceutical and biopharmaceutical companies, contract research organizations, academic and research institutes, and others.

Pharmaceutical and biopharmaceutical companies are the primary end users of single-use bioreactors. These organizations leverage single-use systems for the production of a wide range of therapeutics, including monoclonal antibodies, recombinant proteins, and, notably, vaccines.

Contract Research Organizations (CROs) are significant users of single-use bioreactors, offering outsourced research services to pharmaceutical and biopharmaceutical companies. CROs utilize these systems to conduct various stages of drug development, including preclinical and clinical research.

Academic and research institutes play a crucial role in the innovation and development of new bioprocessing technologies. These institutions use single-use bioreactors for experimental and educational purposes, focusing on the research and development of new drugs, vaccines, and therapeutic proteins.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest single-use bioreactors market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is the largest segment in the single-use bioreactors market by region due to several key factors. The region is home to a robust biopharmaceutical industry with significant investment in research and development. The presence of major pharmaceutical and biotechnology companies, coupled with a strong focus on innovation and advanced manufacturing technologies, drives the demand for single-use bioreactors. Additionally, North America benefits from well-established regulatory frameworks and government support for biopharmaceutical production, particularly in response to public health challenges such as the COVID-19 pandemic.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the single use bioreactors industry include ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players in the single-use bioreactors industry have undertaken several strategic efforts to drive market growth and innovation. Companies such as Thermo Fisher Scientific, Sartorius Stedim Biotech, and GE Healthcare are at the forefront of these initiatives. One major area of focus has been the continuous enhancement of product portfolios through research and development. These companies invest heavily in developing new and improved bioreactor designs that offer greater efficiency, scalability, and ease of use. Innovations such as automated control systems, improved sensors, and better materials for bioreactor components are some of the advancements being pursued.

Latest News:

March 2023: MARQMETRIX launched its latest "SINGLE-USE BIOREACTOR BALL PROVE". This technology reduces the danger of contamination while increasing productivity and lowering expanses.

March 2023: DISTEK launched the latest edition to the BIOne product line, the BIOne 10L Single-Use Bioreactor (SUB).

Key Questions Answered in This Report

  • 1. What was the size of the global single-use bioreactors market in 2023?
  • 2. What is the expected growth rate of the global single-use bioreactors market during 2024-2032?
  • 3. What are the key factors driving the global single-use bioreactors market?
  • 4. What has been the impact of COVID-19 on the global single-use bioreactors market?
  • 5. What is the breakup of the global single-use bioreactors market based on the product type?
  • 6. What is the breakup of the global single-use bioreactors market based on the type?
  • 7. What is the breakup of the global single-use bioreactors market based on the cell type?
  • 8. What is the breakup of the global single-use bioreactors market based on the molecule type?
  • 9. What are the key regions in the global single-use bioreactors market?
  • 10. Who are the key players/companies in the global single-use bioreactors market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Single-use Bioreactor Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Single-use Bioreactor Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Media Bags
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Filtration Assemblies
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Stirred-tank Bioreactors
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Wave-induced Bioreactors
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Bubble-column Bioreactors
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Cell Type

  • 8.1 Mammalian Cells
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Bacteria
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Yeast
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Molecule Type

  • 9.1 Vaccines
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Monoclonal Antibodies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Stem Cells
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Recombinant Proteins
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical and Biopharmaceutical Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Contract Research Organizations
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Academic and Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 ABEC Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Cellexus
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Celltainer Biotech B.V.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 CESCO Bioengineering Co. Ltd.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Distek Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Eppendorf SE
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 SWOT Analysis
    • 16.3.7 General Electric Company
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Getinge AB
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Merck KGaA
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Pall Corporation (Danaher Corporation)
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 SWOT Analysis
    • 16.3.11 PBS Biotech Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Sartorius AG
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Single-use Bioreactor Market: Major Drivers and Challenges
  • Figure 2: Global: Single-use Bioreactor Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Single-use Bioreactor Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Single-use Bioreactor Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Single-use Bioreactor Market: Breakup by Type (in %), 2023
  • Figure 6: Global: Single-use Bioreactor Market: Breakup by Cell Type (in %), 2023
  • Figure 7: Global: Single-use Bioreactor Market: Breakup by Molecule Type (in %), 2023
  • Figure 8: Global: Single-use Bioreactor Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Single-use Bioreactor Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Single-use Bioreactor (Single-use Bioreactor Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Single-use Bioreactor (Single-use Bioreactor Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Single-use Bioreactor (Media Bags) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Single-use Bioreactor (Media Bags) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Single-use Bioreactor (Filtration Assemblies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Single-use Bioreactor (Filtration Assemblies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Single-use Bioreactor (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Single-use Bioreactor (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Single-use Bioreactor (Stirred-tank Bioreactors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Single-use Bioreactor (Stirred-tank Bioreactors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Single-use Bioreactor (Wave-induced Bioreactors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Single-use Bioreactor (Wave-induced Bioreactors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Single-use Bioreactor (Bubble-column Bioreactors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Single-use Bioreactor (Bubble-column Bioreactors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Single-use Bioreactor (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Single-use Bioreactor (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Single-use Bioreactor (Mammalian Cells) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Single-use Bioreactor (Mammalian Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Single-use Bioreactor (Bacteria) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Single-use Bioreactor (Bacteria) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Single-use Bioreactor (Yeast) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Single-use Bioreactor (Yeast) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Single-use Bioreactor (Other Cell Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Single-use Bioreactor (Other Cell Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Single-use Bioreactor (Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Single-use Bioreactor (Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Single-use Bioreactor (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Single-use Bioreactor (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Single-use Bioreactor (Stem Cells) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Single-use Bioreactor (Stem Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Single-use Bioreactor (Recombinant Proteins) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Single-use Bioreactor (Recombinant Proteins) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Single-use Bioreactor (Other Molecule Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Single-use Bioreactor (Other Molecule Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Single-use Bioreactor (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Single-use Bioreactor (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Single-use Bioreactor (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Single-use Bioreactor (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Single-use Bioreactor (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Single-use Bioreactor (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Global: Single-use Bioreactor (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Global: Single-use Bioreactor (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: North America: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: North America: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United States: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United States: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Canada: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Canada: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Asia-Pacific: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Asia-Pacific: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: China: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: China: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Japan: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Japan: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: India: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: India: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: South Korea: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: South Korea: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Australia: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Australia: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Indonesia: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Indonesia: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Europe: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Europe: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Germany: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Germany: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: France: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: France: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: United Kingdom: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: United Kingdom: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Italy: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Italy: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Spain: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Spain: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Russia: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Russia: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Others: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Others: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Latin America: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Latin America: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Brazil: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Brazil: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Mexico: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Mexico: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: Others: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: Others: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032

Figure 98 Middle East and Africa: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023

  • Figure 99: Middle East and Africa: Single-use Bioreactor Market: Breakup by Country (in %), 2023
  • Figure 100: Middle East and Africa: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 101: Global: Single-use Bioreactor Industry: SWOT Analysis
  • Figure 102: Global: Single-use Bioreactor Industry: Value Chain Analysis
  • Figure 103: Global: Single-use Bioreactor Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Single-use Bioreactor Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Single-use Bioreactor Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Single-use Bioreactor Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 4: Global: Single-use Bioreactor Market Forecast: Breakup by Cell Type (in Million US$), 2024-2032
  • Table 5: Global: Single-use Bioreactor Market Forecast: Breakup by Molecule Type (in Million US$), 2024-2032
  • Table 6: Global: Single-use Bioreactor Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Single-use Bioreactor Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Single-use Bioreactor Market: Competitive Structure
  • Table 9: Global: Single-use Bioreactor Market: Key Players